Technical Analysis for HARP - Harpoon Therapeutics, Inc.

Grade Last Price % Change Price Change
grade B 12.52 0.56% 0.07
HARP closed up 0.56 percent on Wednesday, June 26, 2019, on 1.81 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Up Up
See historical HARP trend table...

Date Alert Name Type % Chg
Upper Bollinger Band Walk Strength 0.00%
Outside Day Range Expansion 0.00%
Upper Bollinger Band Touch Strength 0.00%
Stochastic Sell Signal Bearish 0.56%
Slingshot Bullish Bullish Swing Setup 0.56%
Upper Bollinger Band Walk Strength 0.56%
Overbought Stochastic Strength 0.56%
Upper Bollinger Band Touch Strength 0.56%
Bearish Engulfing Bearish -1.42%
Upper Bollinger Band Walk Strength -1.42%

Older signals for HARP ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in developing a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. It is involved in developing HPN424 that is in Phase I clinical trial for the treatment of metastatic castration-resistant prostate cancer; and HPN536 for the treatment of ovarian cancer and other mesothelin expressing tumors, as well as other products targeting tumor-associated antigens for the treatment of multiple myeloma and small-cell lung cancer. The company has a collaboration agreement with AbbVie Biotechnology Ltd. Harpoon Therapeutics, Inc. was founded in 2015 and is headquartered in South San Francisco, California.
Medicine Cancer Medical Specialties Diseases Oncology Immunotherapy Prostate Cancer Cancer Immunotherapy Ovarian Cancer Multiple Myeloma Tumors Proteins Treatment Of Ovarian Cancer Metastatic Castration Resistant Prostate Cancer Neuvenge
Is HARP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 17.85
52 Week Low 9.0651
Average Volume 14,702
200-Day Moving Average 0.0
50-Day Moving Average 11.5012
20-Day Moving Average 11.973
10-Day Moving Average 12.322
Average True Range 0.7261
ADX 24.85
+DI 23.9561
-DI 13.9409
Chandelier Exit (Long, 3 ATRs ) 11.0817
Chandelier Exit (Short, 3 ATRs ) 13.1783
Upper Bollinger Band 13.0106
Lower Bollinger Band 10.9354
Percent B (%b) 0.76
BandWidth 17.332331
MACD Line 0.3295
MACD Signal Line 0.2559
MACD Histogram 0.0736
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.93
Resistance 3 (R3) 13.94 13.48 13.70
Resistance 2 (R2) 13.48 13.12 13.48 13.62
Resistance 1 (R1) 13.00 12.90 13.24 12.99 13.54
Pivot Point 12.54 12.54 12.66 12.54 12.54
Support 1 (S1) 12.06 12.18 12.30 12.05 11.50
Support 2 (S2) 11.60 11.96 11.60 11.42
Support 3 (S3) 11.12 11.60 11.35
Support 4 (S4) 11.11